You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. METTL3-mediated SNHG1 m6A modification promotes proliferation and migration through transcriptional regulation of WDR74 in osteosarcoma
- 2. New AI test can predict which men will benefit from prostate cancer drug
- 3. Landscape of targets within nucleoside metabolism for the modification of immune responses
- 4. TFRC promotes the proliferation, migration, and invasion of osteosarcoma cells by increasing the intracellular iron content and RRM2 expression
- 5. Bi-modal ultrasound radiomics and habitat analysis enhanced the pre-operative prediction of axillary lymph node burden in patients with early-stage breast cancer
- 6. Advances on cancer vaccine trials registered in China and the USA in 2014-2024
- 7. Unveiling the impact of lipid metabolism on triple-negative breast cancer growth and treatment options
- 8. Enhanced coagulation index: a potent prognostic indicator for clinical outcomes in non-metastatic breast cancer following surgery and adjuvant therapy
- 9. Intensity Therapeutics, Inc.'s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
- 10. Accelerating cancer genomics research in Sub-Saharan Africa
Last updated at 21:53 GMT
Hot News Makers
Health/Pharma Companies
-
182337.54
-
41714.83
-
40779.29
-
39814.22
-
24621.04
-
12047.27
-
11988.80
-
10262.34
-
7754.84
-
7233.02
Drugs, Treatments, Trials
-
34449.11
-
21847.75
-
20054.98
-
10874.72
-
10414.69
-
8313.77
-
7458.02
-
6450.18
-
5553.33
-
5344.89
Last updated at 21:10 GMT
